Despite apparently discrepant AKI outcomes in global vs. myeloid cell-specific IL-1R1 knockout mouse strains, both models provide conceptual support for pharmacological suppression of IL-1 signaling in AKI. The gene discussed is IL1A; the disease is acute kidney injury.